These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 10430939)
1. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939 [TBL] [Abstract][Full Text] [Related]
2. Kinetic evolution of a diabetogenic CD8+ T cell response. Santamaria P Ann N Y Acad Sci; 2003 Nov; 1005():88-97. PubMed ID: 14679043 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. DiLorenzo TP; Graser RT; Ono T; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12538-43. PubMed ID: 9770521 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161 [TBL] [Abstract][Full Text] [Related]
5. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. Verdaguer J; Schmidt D; Amrani A; Anderson B; Averill N; Santamaria P J Exp Med; 1997 Nov; 186(10):1663-76. PubMed ID: 9362527 [TBL] [Abstract][Full Text] [Related]
7. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915 [TBL] [Abstract][Full Text] [Related]
8. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172 [TBL] [Abstract][Full Text] [Related]
9. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754 [TBL] [Abstract][Full Text] [Related]
10. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes. Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095 [TBL] [Abstract][Full Text] [Related]
11. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. Kanagawa O; Shimizu J; Vaupel BA J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914 [TBL] [Abstract][Full Text] [Related]
12. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. Wong CP; Li L; Frelinger JA; Tisch R J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193 [TBL] [Abstract][Full Text] [Related]
13. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247 [TBL] [Abstract][Full Text] [Related]
14. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897 [TBL] [Abstract][Full Text] [Related]
15. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway. Gurlo T; Kawamura K; von Grafenstein H J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259 [TBL] [Abstract][Full Text] [Related]
16. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483 [TBL] [Abstract][Full Text] [Related]
17. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685 [TBL] [Abstract][Full Text] [Related]
18. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. Shimizu J; Kanagawa O; Unanue ER J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546 [TBL] [Abstract][Full Text] [Related]
19. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity. Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001 [TBL] [Abstract][Full Text] [Related]
20. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]